Skip to main content
Vivatmo for Doctors
ERS 2025

Vivatmo: Easy FeNO Testing – Anytime and Anywhere

Join us at our booth at ERS 2025 in Amsterdam – discover the latest Vivatmo innovations and insights on the biomarker FeNO.

September 27 - October 01, 2025
RAI Amsterdam, NL
Blond Women exhaling in the Vivatmo me device in the kitchen

Join Bosch at ERS 2025 in Amsterdam!

Bosch will be at Europe’s leading congress for respiratory experts, showcasing Vivatmo – the easy-to-use FeNO system that delivers reliable results without sensor maintenance.

Highlights:

  • Live demo: Try Vivatmo’s latest app feature – exhale into the handheld device and watch your exhalation flow in real time on the app or on our big screen at the booth.*
  • Scientific insights: Get the latest FeNO@home study results, explore poster sessions referencing Vivatmo and FeNO, and join the presentations at our booth.
  • Vivatmo system: See how easy FeNO testing can be and discover Bosch’s engineering expertise, pioneering maintenance-free sensors.

The Vivatmo Team can’t wait to see you in Hall 1, Booth D18!

ERS 2025 logo
European Respiratory Society International Congress 2025

Constantly Refining the Joy of Use

The Vivatmo app now features a new real-time guidance, adding even more joy and ease to FeNO home testing.* The visualization provides direct feedback to the user on whether exhalation is too soft, too strong, or just right. While the FeNO@home study has already confirmed excellent ratings for usability, adherence, and physician satisfaction, we have further enhanced the user experience to make home use smoother than ever.

Join our live demo at the booth!

New feature: The Vivatmo app shows real-time exhalation flow to simplify home measurement.
New feature: The Vivatmo app shows real-time exhalation flow to simplify home measurement.*
Feasability Metrics FeNO@home Study
The FeNO@home study has confirmed excellent usability, adherence, and physician satisfaction for Vivatmo me.
/

Discover More at the Vivatmo Booth

Remote visit
Superior Bosch SensorTech

Maintenance-Free for Life

Bosch’s pioneering sensor technology combines decades of R&D expertise with cutting-edge manufacturing. Bosch sensors are used worldwide in many applications, including cars, smartphones, and medical devices. Backed by thousands of patents and millions of sensors produced daily, Bosch ensures reliable and robust performance. Evolved from this experience, the outstanding Vivatmo sensor technology works with smart algorithms and resists chemical aging. Discover at our booth why our sensor is truly maintenance-free throughout the entire lifetime.

FeNO home study: Patient and doctor talking online
Benefits for Study Initiators and CROs

Cost-Effective Data Enhancement

Contract research organizations and study initiators can benefit from FeNO home monitoring in multiple ways. Using the Vivatmo me, they can reduce the expenses for data collection through fewer on-site visits and lower device costs. More FeNO values can be collected during the observation period and the data can be enriched with patient-entered app information such as symptoms, medication, or allergen exposure. The use of more and enriched data can boost clinical insights and enable more flexible study designs.

Let's find out together how we can support your next study!

Vivatmo App and FeNO report
FeNO for Clinical and Home Use

The Key to Asthma Remission

FeNO has become an essential component in modern asthma diagnosis and management. Increasingly endorsed by leading guidelines and supported by a growing body of studies, this inflammation marker plays a pivotal role on the path to clinical remission. From patient phenotyping and risk detection to drug indication, response monitoring, and adherence checks – FeNO enables a more precise and personalized approach to asthma care. Discover the latest insights and clinical benefits of this emerging biomarker at our booth.

ERS 2025: Poster Sessions related to Vivatmo
[Poster area is marked on the Floorplan]
  1. DE Bosch/Beeh: Home-based FeNO measurement in GINA 1-5 asthma: the FeNO@home study (Monday, 29.09.2025, 8:00-9:30, PS-14, PA2530)
  2. NL Leiden/Meulmeester: Impact of Home Monitoring on Exacerbations After Alpine Altitude Climate Treatment: Davos@Home  (Monday, 29.09.2025, 8:00-9:30, PS-14, PA2535)
  3. DE Freiburg/Gashynova (Dnipro, Ukraine): Exhaled Nitric Oxide Measurements to Predict the Risk of Exacerbations in COPD (HOPE): A feasibility study (Monday, 29.09.2025, 8:00-9:30, PS-14, PA2538)
  4. DE Schönklinik/Glöckl: Intra- and Inter-Day Variability of FeNO in Asthma Patients During Inpatient Pulmonary Rehabilitation (Monday, 29.09.2025, 8:00-9:30, PS-2, PA2649)
  5. UK Glasgow/Logan (BenRex): Improvements in FEV1 and St George’s Respiratory Questionnaire (SGRQ) at 4 and 16 weeks on benralizumab are strongly associated with clinical remission at 1 year (Tuesday, 30.09.2025, 8:00-9:30, PS-13, PA4619)
  6. NZ Mrinz/Noble: Late Breaking Abstract - Budesonide-formoterol vs terbutaline reliever in adults with asthma using maintenance inhaled corticosteroids (Tuesday, 30.09.2025, 8:00-9:30, PS-20, PA4782)

Bosch Vivatmo System

FeNO in Medical Practice & FeNO at Home for Optimized Asthma Therapy

The Vivatmo system consisting of Vivatmo pro, me, digital asthma diary and checklist shown in a circle.
Adapted from Global Initiative for Asthma (GINA): Continuous cycle of personalized asthma management consisting of assessment, adjustment of treatment, and review. All steps are under the supervision of the treating physician.

The biomarker FeNO plays a central role in the diagnosis and therapy of asthma. Bosch Vivatmo measures the FeNO level in exhaled breath simply and precisely. The Vivatmo system is built on two pillars:

  • Vivatmo pro for FeNO measurement in medical practices and clinics.
  • Vivatmo me for FeNO measurement at patient's home.
Home measurement also includes the free Vivatmo app, which serves as an asthma diary and digital link between doctor and patient. In addition, the disposable Vivatmo oxycap mouthpieces ensure maximum hygiene and reliable results for each measurement.

Regarding FeNO, the combination of clinical and home testing is unique worldwide. It opens up completely new dimensions in asthma management: Home monitoring provides the treating physician with more relevant patient data and measurement points. This can enable more precise dosing of medication, better control of adherence and exacerbations in dialogue with the patient.

What Makes Vivatmo Special?

The FeNO System Connecting Physicians and Patients for Optimized Asthma Management

Holistic system approach

Worldwide unique combination: FeNO in medical practice & FeNO at home for individual, need-based therapy in dialogue with the patient – for precise medication, better control of adherence and exacerbations.

Exceptional cost-efficiency

The Vivatmo system requires no recalibration, maintenance, or sensor exchange during the entire lifetime due to high-precision Bosch technology made in Germany.

Flexible operation

Portable, wireless handheld allows mobile measurements. Data is subsequently transmitted to Vivatmo app or basestation via Bluetooth.

*The new feature is planned to be released with the next app update for Android and iOS, available in the app stores in October (subject to change).

This website contains general product information about the Vivatmo system from Bosch. Not all products and their functions mentioned here are approved in every regional market. For a detailed description of the products and features as well as information on intended and safe use, please refer to your locally authorized Bosch distribution partner and the instructions for use that are valid for your country.